NDC 26436-5500-3
This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.
- Requested NDC
- 26436-5500-3
- Product root
- 26436-5500
- Identity scope
- Package
- Primary current NDC product row
- Not present
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| compounder | package | 26436-5500 | 26436-5500-3 | COMPOUNDER | Outsourcing facility compounded drug report | 2021-2 | 2026-08-10 |
| compounder | package | 26436-5500 | 26436-5500-3 | COMPOUNDER | Outsourcing facility compounded drug report | 2020-2 | 2026-08-10 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-27 00:00 UTC · source 2025-08-20 | compounder | package | 26436-5500 | 26436-5500-3 | COMPOUNDER | Outsourcing facility compounded drug report | 2021-2 | compounder / compounders_ndc_directory.zip | af8e9b524e63… | ca326a94a5e9… |
| 2025-08-27 00:00 UTC · source 2025-08-20 | compounder | package | 26436-5500 | 26436-5500-3 | COMPOUNDER | Outsourcing facility compounded drug report | 2020-2 | compounder / compounders_ndc_directory.zip | af8e9b524e63… | ca326a94a5e9… |
| 2022-05-13 07:20 UTC · source 2022-04-19 | compounder | package | 26436-5500 | 26436-5500-3 | COMPOUNDER | Outsourcing facility compounded drug report | 2021-2 | compounder / compounders_ndc_directory.zip | 4694734df12d… | db2bf3a0aaab… |
Compounder NDC reports#
| Establishment | FEI | Product NDC | Package NDC | Product | Active ingredients | Reporting period | Normalization |
|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 079665742 | 26436-5500 | 26436-5500-3 | Buprenorphine Hydrochloride | .4 mg/1 mL | 2021-2 | valid |
| Hybrid Pharma | 079665742 | 26436-5500 | 26436-5500-3 | Buprenorphine Hydrochloride | .4 mg/1 mL | 2020-2 | valid |
| Hybrid Pharma | 079665742 | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | .4 mg/1 mL | 2025-2 | valid |
| Hybrid Pharma | 26436-5500 | 26436-5500-1 | Buprenorphine 0.4mg/mL PF | .4 mg/1 mL | 2025-1 | valid | |
| Hybrid Pharma | 079665742 | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | .4 mg/1 mL | 2025-1 | valid |
| Hybrid Pharma | 26436-5500 | 26436-5500-1 | Buprenorphine 0.4mg/mL PF | .4 mg/1 mL | 2024-2 | valid | |
| Hybrid Pharma | 079665742 | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | .4 mg/1 mL | 2024-2 | valid |
| Hybrid Pharma | 26436-5500 | 26436-5500-1 | Buprenorphine 0.4mg/mL PF | .4 mg/1 mL | 2024-1 | valid | |
| Hybrid Pharma | 079665742 | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | .4 mg/1 mL | 2024-1 | valid |
| Hybrid Pharma | 26436-5500 | 26436-5500-1 | Buprenorphine 0.4mg/mL PF | .4 mg/1 mL | 2023-2 | valid | |
| Hybrid Pharma | 079665742 | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | .4 mg/1 mL | 2023-2 | valid |
| Hybrid Pharma | 079665742 | 26436-5500 | 26436-5500-1 | Buprenorphine Hydrochloride | .4 mg/1 mL | 2023-1 | valid |